RIVASTIGMINE GenPar PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

rivastigmine, Quantity: 27 mg

Доступна с:

Arrotex Pharmaceuticals Pty Ltd

ИНН (Международная Имя):

Rivastigmine

Фармацевтическая форма:

Drug delivery system, transdermal

состав:

Excipient Ingredients: acrylates copolymer; ethyl acetate; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer; methylated trimethylated silica

Администрация маршрут:

Transdermal

Штук в упаковке:

7 sachets, 30 sachets

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

RIVASTIGMINE GENPAR PATCH is indicated for the treatment of patients with mild, moderate and severe dementia of the Alzheimer?s type.

Обзор продуктов:

Visual Identification: Circular 15cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with "Rivastigmine 13.3 mg/24 h"; Container Type: Sachet; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2017-01-25